OptimizeRx appoints James Lang to board of directors
Mr. Lang brings to OptimizeRx more than 25 years of experience in healthcare data, analytic, and technology enabled business services.
Mr. Lang presently serves as an executive advisor to Water Street, a strategic private equity firm focused exclusively on building market-leading companies in healthcare. Mr. Lang is also a director of BioVie, a development-stage company.
Mr. Lang previously served as CEO of Decision Resources Group, a healthcare research and consulting company.
Earlier, he was president of Strategic Decisions Group, a premier global strategy consultancy, and he expanded the life sciences practice and later sold it to IMS Health.
He is an active private investor and advisor with healthcare companies, including Boston Heart Diagnostics (acquired by Eurofins) and AlphalmpactRx (acquired by IMS Health).
Mr. Lang holds a BS summa cum laude in electrical and computer engineering from the University of New Hampshire, and earned an MBA with distinction from the Tuck School of Business where he was named an Edward Tuck Scholar.
He currently guest lectures at the Tuck School of Business in strategy and decision-making. ■
What to read next
LATEST MOVES FROM Michigan
- Rockwell Medical appoints John G. Cooper to board
- Penske Automotive Group appoints Greg Smith as director
- Neogen appoints John Adent as CEO
- American Axle & Manufacturing: Olaf Bongwald president AAM Driveline – Europe
- Bruk Herbst joins Zomedica Pharmaceuticals as CCO
More inside POST
Richard Branson invests in Hyperloop One Companies
Sinopec's net profit surges 40% Earnings